BOSS ZHIPIN-W
02076
TME-SW
01698
BIDU-SW
09888
NTES-S
09999
JD HEALTH
06618
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 27.15%31.39B | 37.99%23.47B | 52.29%16.22B | 70.60%8.26B | 368.52%24.68B | 335.80%17.01B | 231.15%10.65B | 131.19%4.84B | -44.02%5.27B | -43.92%3.9B |
Operating income | 27.15%31.39B | 52.29%16.22B | 368.52%24.68B | 231.15%10.65B | -44.02%5.27B | |||||
Operating expenses | ||||||||||
Gross profit | ||||||||||
Employee expense | -18.72%-4.7B | ---- | -28.05%-2.28B | ---- | -29.63%-3.96B | ---- | -15.51%-1.78B | ---- | 3.01%-3.05B | ---- |
Depreciation and amortization | 1.69%-1.85B | ---- | 3.50%-921.37M | ---- | 7.25%-1.89B | ---- | 7.67%-954.78M | ---- | 5.74%-2.03B | ---- |
Impairment and provision | -29.61%-50.82M | ---- | -496.09%-31.85M | ---- | 22.53%-39.21M | ---- | 80.43%-5.34M | ---- | 59.54%-50.61M | ---- |
-Other impairment is provision | -29.61%-50.82M | ---- | -496.09%-31.85M | ---- | 22.53%-39.21M | ---- | 80.43%-5.34M | ---- | 59.54%-50.61M | ---- |
Special items of operating profit | -37.98%-4.75B | ---- | -60.27%-2.22B | ---- | -139.60%-3.44B | ---- | -84.59%-1.39B | ---- | 31.11%-1.44B | ---- |
Operating profit | 35.38%6.16B | 88.70%3.52B | 225.99%4.55B | 222.48%1.87B | -53.69%-3.61B | |||||
Financing income | -9.41%75.2M | ---- | -12.27%40.03M | ---- | 15.78%83.02M | ---- | 2,018.62%45.64M | ---- | 1,397.29%71.71M | ---- |
Financing cost | 13.41%-1.66B | ---- | 14.33%-838.55M | ---- | -14.91%-1.91B | ---- | -33.06%-978.77M | ---- | -20.37%-1.67B | ---- |
Special items of earning before tax | 378.07%88.83M | ---- | 93.35%-6.97M | ---- | -144.38%-31.95M | ---- | 24.55%-104.73M | ---- | 87.01%-13.07M | ---- |
Earning before tax | 73.69%4.66B | 227.83%2.72B | 151.48%2.69B | 134.58%828.73M | -36.26%-5.22B | |||||
Tax | -28.65%-60.12M | ---- | -301.51%-31.39M | ---- | -196.90%-46.74M | ---- | 1.52%-7.82M | ---- | 15.44%-15.74M | ---- |
After-tax profit from continuing operations | 74.48%4.6B | 227.13%2.69B | 150.43%2.64B | 134.15%820.91M | -36.01%-5.23B | |||||
Earning after tax | 74.48%4.6B | 227.13%2.69B | 150.43%2.64B | 134.15%820.91M | -36.01%-5.23B | |||||
Profit attributable to shareholders | 74.48%4.6B | 227.13%2.69B | 150.43%2.64B | 134.15%820.91M | -36.01%-5.23B | |||||
Basic earnings per share | 74.50%1.211 | 226.85%0.706 | 150.40%0.694 | 134.12%0.216 | -36.07%-1.377 | |||||
Diluted earnings per share | 74.28%1.206 | 226.51%0.702 | 150.25%0.692 | 133.97%0.215 | -36.07%-1.377 | |||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.